Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ

<p>Abstract</p> <p>Background</p> <p>The aim of this study was to measure HrQoL during acute exacerbations of COPD using generic and disease-specific instruments, and to assess completeness, proportion with best or worst health state, sensitivity to change and discrimin...

Full description

Bibliographic Details
Main Authors: Holle Rolf, Weber Norbert, Menn Petra
Format: Article
Language:English
Published: BMC 2010-04-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/8/1/39
_version_ 1811284486698041344
author Holle Rolf
Weber Norbert
Menn Petra
author_facet Holle Rolf
Weber Norbert
Menn Petra
author_sort Holle Rolf
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The aim of this study was to measure HrQoL during acute exacerbations of COPD using generic and disease-specific instruments, and to assess completeness, proportion with best or worst health state, sensitivity to change and discriminative ability for each instrument.</p> <p>Methods</p> <p>EQ-5D, SF-12 and SGRQ were obtained from COPD patients with GOLD stage III and IV hospitalized for an acute exacerbation both at admission and discharge. To assess the instruments' properties, utility values were calculated for EQ-5D and SF-12, and a total score was derived from the SGRQ.</p> <p>Results</p> <p>Mean utilities ranged from 0.54 (SF-12, stage IV) to 0.62 (EQ-5D, stage III) at admission, and from 0.58 (SF-12, stage IV) to 0.84 (EQ-5D, stage III) at discharge. Completeness was best for EQ-5D and SGRQ, while no utility value for the SF-12 could be calculated for more than 30%. For SGRQ subscales, the minimal score occurred in up to 11% at admission, while full health was observed for the EQ-5D at discharge in 13%. Sensitivity to change was generally good, whereas discrimination between COPD stages was low for the EQ-5D.</p> <p>Conclusions</p> <p>Acute exacerbations seriously impair health status and quality of life. The EQ-5D is generally suitable to measure HrQoL in exacerbations of severe COPD, although the high proportion of patients reporting full health at discharge poses a problem. The main issue with the SF-12 is the high proportion of missing values in a self-assessed setting. Properties of the SGRQ were satisfactory. However, since no utility values can be derived from this disease-specific instrument, it is not suitable for cost-utility analyses in health-economic evaluations.</p>
first_indexed 2024-04-13T02:29:23Z
format Article
id doaj.art-745f4b1ec96c4eeabc86e32dae85651c
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-04-13T02:29:23Z
publishDate 2010-04-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-745f4b1ec96c4eeabc86e32dae85651c2022-12-22T03:06:38ZengBMCHealth and Quality of Life Outcomes1477-75252010-04-01813910.1186/1477-7525-8-39Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQHolle RolfWeber NorbertMenn Petra<p>Abstract</p> <p>Background</p> <p>The aim of this study was to measure HrQoL during acute exacerbations of COPD using generic and disease-specific instruments, and to assess completeness, proportion with best or worst health state, sensitivity to change and discriminative ability for each instrument.</p> <p>Methods</p> <p>EQ-5D, SF-12 and SGRQ were obtained from COPD patients with GOLD stage III and IV hospitalized for an acute exacerbation both at admission and discharge. To assess the instruments' properties, utility values were calculated for EQ-5D and SF-12, and a total score was derived from the SGRQ.</p> <p>Results</p> <p>Mean utilities ranged from 0.54 (SF-12, stage IV) to 0.62 (EQ-5D, stage III) at admission, and from 0.58 (SF-12, stage IV) to 0.84 (EQ-5D, stage III) at discharge. Completeness was best for EQ-5D and SGRQ, while no utility value for the SF-12 could be calculated for more than 30%. For SGRQ subscales, the minimal score occurred in up to 11% at admission, while full health was observed for the EQ-5D at discharge in 13%. Sensitivity to change was generally good, whereas discrimination between COPD stages was low for the EQ-5D.</p> <p>Conclusions</p> <p>Acute exacerbations seriously impair health status and quality of life. The EQ-5D is generally suitable to measure HrQoL in exacerbations of severe COPD, although the high proportion of patients reporting full health at discharge poses a problem. The main issue with the SF-12 is the high proportion of missing values in a self-assessed setting. Properties of the SGRQ were satisfactory. However, since no utility values can be derived from this disease-specific instrument, it is not suitable for cost-utility analyses in health-economic evaluations.</p>http://www.hqlo.com/content/8/1/39
spellingShingle Holle Rolf
Weber Norbert
Menn Petra
Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
Health and Quality of Life Outcomes
title Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
title_full Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
title_fullStr Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
title_full_unstemmed Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
title_short Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
title_sort health related quality of life in patients with severe copd hospitalized for exacerbations comparing eq 5d sf 12 and sgrq
url http://www.hqlo.com/content/8/1/39
work_keys_str_mv AT hollerolf healthrelatedqualityoflifeinpatientswithseverecopdhospitalizedforexacerbationscomparingeq5dsf12andsgrq
AT webernorbert healthrelatedqualityoflifeinpatientswithseverecopdhospitalizedforexacerbationscomparingeq5dsf12andsgrq
AT mennpetra healthrelatedqualityoflifeinpatientswithseverecopdhospitalizedforexacerbationscomparingeq5dsf12andsgrq